Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ndt/gfq602PMID 20935019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease.

  2010cited by this paper
• KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

  2009cited by this paper
• Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD)

  2009cited by this paper
• Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.

  2009cited by this paper
• Evaluation of a phosphate management protocol to achieve optimum serum phosphate levels in hemodialysis patients.

  2008cited by this paper
• Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.

  2008cited by this paper
• Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.

  2007cited by this paper
• Improving patient care

  2007cited by this paper
• Chronic kidney disease-mineral-bone disorder: a new paradigm.

  2007cited by this paper
• Patient Empowerment in the Management of Hyperphosphatemia

  2007cited by this paper
• The CARI guidelines. Management of bone disease, calcium, phosphate and parathyroid hormone.

  2006cited by this paper
• Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.

  2006cited by this paper
• Management of Bone Disease, Calcium, Phosphate and Parathyroid Hormone

  2006cited by this paper
• The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.

  2005cited by this paper
• Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.

  2005cited by this paper
• Chronic kidney disease as cause of cardiovascular morbidity and mortality.

  2005cited by this paper
• Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review.

  2005cited by this paper
• Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes.

  2004cited by this paper
• Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

  2004cited by this paper
• The effect of diet education on the laboratory values and knowledge of hemodialysis patients with hyperphosphatemia.

  2004cited by this paper
• Clinical skills: empowering people with diabetes to minimize complications.

  2004cited by this paper
• Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

  2004cited by this paper
• Achieving K/DOQI Laboratory Target Values for Bone and Mineral Metabolism: An Uphill Battle

  2004cited by this paper
• A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients.

  2003cited by this paper
• K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

  2003cited by this paper
• Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

  2003cited by this paper
• Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

  2001cited by this paper
• The effect of an educational patient compliance program on serum phosphate levels in patients receiving hemodialysis.

  2000cited by this paper
• Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

  2000cited by this paper
• Interventions to improve the delivery of preventive services in primary care.

  1999cited by this paper
• Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

  1998cited by this paper
• Clinical epidemiology of cardiovascular disease in chronic renal disease.

  1998cited by this paper
• Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines

  1997cited by this paper

• Correlations of Parathormone and Biochemical Parameters in Chronic Kidney Disease

  2026cites this paper
• Patient Adherence and the Serum Phosphate, Calcium, and Intact Parathyroid Hormone Control in Peritoneal Dialysis Patients: Effectiveness of Smart PD Care Program

  2025cites this paper
• Effect of a transtheoretical model-based intervention and motivational interviewing on hyperphosphatemia management via telehealth (TMT program) among hemodialysis patients during the COVID-19 pandemic

  2024cites this paper
• To study the effect of dietary modification on Hemodialysis patients

  2023cites this paper
• The current status of chronic kidney disease-mineral and bone disorder management in China

  2022cites this paper
• Assessment of treatment burden and its impact on quality of life in dialysis-dependent and pre-dialysis chronic kidney disease patients in Qatar.

  2021cites this paper
• The optimal range of serum intact parathyroid hormone for a lower risk of mortality in the incident hemodialysis patients

  2021cites this paper
• Impact of community pharmacist-led intensive education on the control of serum phosphate levels in haemodialysis patients

  2020cites this paper
• Caskey, F. (2017). Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country’s healthcare expenditure and nephrologist workforce? Nephrology Dialysis Transplantation , 32 (10).

  2019cites this paper
• Multidisciplinary education approach to optimize phosphate control among hemodialysis patients

  2019cites this paper
• Dialysis‐related practice patterns among hemodialysis patients with cancer

  2018cites this paper
• Health Teachings Rendered to Hemodialysis Patients as Perceived by Hemodialysis Patients and Staff Nurses

  2018cites this paper
• CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?

  2017cites this paper
• Mineral and bone disorder: can the way teams work make a difference?

  2017cites this paper
• One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis

  2017cites this paper
• Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country’s healthcare expenditure and nephrologist workforce?

  2017cites this paper
• Die vielen Gesichter von Phosphat in der Ernährung

  2017cites this paper
• Phosphate binder pill burden, patient‐reported non‐adherence, and mineral bone disorder markers: Findings from the DOPPS

  2016cites this paper
• The prescription of a higher number of phosphate binder pills is associated with lower medication adherence and worse serum phosphorus control

  2016cites this paper
• Achievement of NKF/K-DOQI Recommended Target Values for Bone and Mineral Metabolism in Incident Hemodialysis Patients: Results of the FARO-2 Cohort

  2016cites this paper
• Development and Evaluation of the Psychometric Properties of the CKD-MBD Knowledge and Behavior (CKD-MBD-KB) Questionnaire for Patients With Chronic Kidney Disease.

  2016cites this paper
• Communication during haematological consultations; patients’ preferences and professionals’ performances

  2016cites this paper
• Patient kidney disease knowledge remains inadequate with standard nephrology outpatient care

  2015cites this paper
• A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on Dialysis

  2015cites this paper
• Adherence to phosphate binders: improving patient engagement

  2015cites this paper
• AN OVERVIEW OF NURSES' MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM: HOW IS EUROPE DOING?

  2015cites this paper
• Influencing factors for high quality care on postpartum haemorrhage in the Netherlands: patient and professional perspectives

  2015cites this paper
• Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

  2015cites this paper
• Managing serum phosphate in haemodialysis patients: time for an innovative approach?

  2014cites this paper
• Variability in parathyroid hormone assays confounds clinical practice in chronic kidney disease patients

  2014cites this paper
• Quality of survey reporting in nephrology journals: a methodologic review.

  2014cites this paper
• Management of mineral metabolism in hemodialysis patients: discrepancy between interventions and perceived causes of failure

  2014cites this paper
• Achievement of NKF/K-DOQI Recommended Target Values for Bone and Mineral Metabolism in Incident Hemodialysis Patients: Results of the FARO-2 Cohort

  2014cites this paper
• Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines.

  2014cites this paper
• Kidney disease health literacy among new patients referred to a nephrology outpatient clinic

  2014cites this paper
• Reasons for phosphate binder discontinuation vary by binder type.

  2014cites this paper
• Delivering high-quality care to patients with a non-Hodgkin's lymphoma: barriers perceived by patients and physicians.

  2014cites this paper
• Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence

  2013cites this paper
• The impact of nurse-led education on haemodialysis patients' phosphate binder medication adherence.

  2013cites this paper
• Effect of a dietitian-managed bone algorithm on serum phosphorus level in maintenance hemodialysis patients.

  2013cites this paper
• Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis

  2013cites this paper
• COSMOS: the dialysis scenario of CKD-MBD in Europe.

  2013cites this paper
• Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary - results from a nationwide clinical audit

  2013cites this paper
• Compliance with Mineral Metabolism Targets in Haemodialysis Patients: Moving Backwards?

  2013cites this paper
• Association of serum fetuin-A and fetuin-A gene polymorphism in relation to mineral and bone disorders in patients with chronic kidney disease

  2013cites this paper
• Conhecimentos, adesão e barreiras ao tratamento da hiperfosfatemia em insuficientes renais crónicos em programa regular de hemodiálise.

  2012cites this paper
• Medication Reminder Systems: An Adjunct Technique in Improving Phosphate Binder Adherence

  2012cites this paper
• A novel, 12-week, nurse-led motivation and education programme has no effect on serum phosphate levels in haemodialysis patients

  2012cites this paper
• Hemodialyssjuksköterskors kunskap om fosfatrika livsmedel : - en enkätstudie

  2012cites this paper
• In order to improve CKD – MBD outcomes , in 2003 , the National Kidney Foundation launched the Kidney Dialysis

  2012cites this paper
• Chronic kidney disease-mineral bone disorder (CKD-MBD) management and associated cost in an Irish haemodialysis cohort.

  2011cites this paper